Four of nine checkpoint inhibitor-sensitive patients experienced RECIST responses post vaccination; median duration without disease progression after initial GEN-009 vaccination was 15 months Two of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback